Med-IQ

Course Listings: Oncology

Course Description: In this 2-hour webcast, experts explore the emerging science and research of targeting the FGFR signaling pathway and the current and future clinical applications of FGFR inhibitors in cancer care. A panel of experts then discuss how this science can be incorporated into practice.

Course Description: This brief accredited CME activity explores the rationale for, and importance of, the first phase 3 study investigating the use of stem cell transplantation with omidubicel, an ex vivo expanded umbilical cord blood stem cell graft to unmanipulated umbilical cord blood transfusion. In addition, it reviews and interprets the results of the study and translates…More

Course Description: In this 2-hour webcast, experts explore the emerging science and research of targeting the FGFR signaling pathway and the current and future clinical applications of FGFR inhibitors in cancer care. A panel of experts then discuss how this science can be incorporated into practice.

Course Description: This 45-minute, accredited CME activity discusses the pathophysiology of cutaneous squamous cell carcinoma (CSCC), rationale for the development of immune checkpoint inhibitors for this condition, current and emerging treatment approaches, and the importance of care coordination for patients with advanced CSCC. A case vignette highlights the appropriate…More

Course Description: This 15-minute, accredited CME publication follows the case of a patient who was referred to a gynecologist for uterine fibroids and heavy bleeding. Dr. Rebecca A. Previs provides insight on diagnosing this patient with Lynch syndrome and discusses current best practices for managing patients with this condition.

Course Description: This 30-minute accredited CME activity discusses the role of HER3 in cancer progression and treatment resistance in breast cancer and non–small cell lung cancer (NSCLC) and explores investigational therapies targeting HER3. In addition, brief audio clips provide expert perspectives about HER3-targeting agents and how they are expected to affect patient care for…More

Course Description: In this 2-hour webcast, experts explore the emerging science and research of targeting the FGFR signaling pathway and the current and future clinical applications of FGFR inhibitors in cancer care. A panel of experts then discuss how this science can be incorporated into practice.

Course Description: This 30-minute activity explores the role of fibroblast growth factor receptor (FGFR) alterations in urothelial cancer (UC) pathogenesis and provides a summary of efficacy and safety data for available and emerging selective FGFR tyrosine kinase inhibitors for the treatment of UC. Whiteboard animation videos are used to show how these FGFR aberrations act as…More

Course Description: In this case-based activity, meet 2 patients with advanced non–small cell lung cancer (NSCLC) who are starting treatment. How would you manage these patients? As you move through this activity, you will:See how your answers compare with your peers’ Read commentary on the answer optionsReview insights from medical oncologist, Suresh Ramalingam,…More